What is a Fibroscan?
A Fibroscan (also known as transient elastography) is a non-invasive, painless diagnostic test that uses ultrasound technology to measure liver stiffness and fat accumulation. It is primarily used to detect early signs of liver fibrosis (scarring) and steatosis (fatty liver), serving as a safer, faster alternative to a traditional liver biopsy.
Why Liver Disease Is Called the "Silent Killer"
Chronic liver disease typically produces no symptoms in its early-to-mid stages. Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), Hepatitis B, or Hepatitis C can have severely damaged livers while feeling perfectly well — and their routine blood liver function tests may even appear normal.
Critical fact: Approximately 50% of patients who first present with advanced symptoms of cirrhosis — such as jaundice, fluid in the abdomen, or gastrointestinal bleeding — die within 12 to 18 months of that diagnosis. Early detection is life-saving.
Common Causes of Chronic Liver Disease
Non-Alcoholic Fatty Liver Disease (NAFLD)
The most common cause, affecting roughly one-third of Indians. Driven by poor diet, physical inactivity, excess abdominal fat, and abnormal blood sugar or lipid levels.
Chronic Hepatitis B & C infections
Viral infections that progressively scar the liver over years or decades with minimal early symptoms.
Excessive alcohol consumption
Sustained heavy drinking directly damages liver cells and accelerates fibrosis.
How a Fibroscan Test Works: Step by Step
Positioning
You lie on your back with your right arm raised behind your head, exposing the right side of your ribcage. No change of clothes or hospital gown is needed.
Probe Placement
The operator applies a small amount of ultrasound gel to your skin and places the Fibroscan probe between your ribs over the right lobe of the liver.
Measurements Taken
The device sends a gentle vibration pulse and records how fast the resulting elastic wave travels through the liver. Ten valid measurements are taken and averaged for accuracy.
CAP Score Recorded Simultaneously
During the same pass, the CAP algorithm analyses ultrasound signal attenuation to quantify the proportion of the liver affected by fat deposits.
Results Within Minutes
The full procedure takes approximately 15 minutes. Results are available immediately. You can resume normal activities right away — no recovery time required.
What is IQR/M on a Fibroscan report? IQR (Interquartile Range) reflects the variability between your 10 measurements.
An IQR/M ratio below 30% indicates reliable, consistent results. A higher ratio may mean the test should be repeated.
Understanding Your CAP Score (Liver Fat)
The CAP score measures the proportion of your liver that has been infiltrated by fat, expressed in decibels per metre (dB/m). It directly diagnoses steatosis — the medical term for fatty liver.
| CAP Score | Steatosis Grade | Liver Affected | Severity |
|---|---|---|---|
| Below 238 dB/m | S0 | Less than 11% | Normal |
| 238 – 260 dB/m | S1 | 11% – 33% | Mild |
| 260 – 290 dB/m | S2 | 34% – 66% | Moderate |
| 290 – 400 dB/m | S3 | More than 67% | Severe |
A higher CAP score means more fat in the liver and a greater risk of progression to fibrosis and cirrhosis if underlying causes are not addressed. The CAP score is particularly useful for diagnosing and monitoring NAFLD, the most common liver disease in India.
Understanding Your Fibrosis Score (Liver Stiffness in kPa)
The liver stiffness measurement (LSM) is reported in kilopascals (kPa) and maps to a fibrosis stage from F0 to F4. The table below shows disease-specific cut-offs, because the same kPa value can mean different stages depending on the cause of liver disease.
| Condition | F0–F1 (None/Mild) | F2 (Moderate) | F3 (Severe) | F4 (Cirrhosis) |
|---|---|---|---|---|
| Hepatitis B | 2–7 kPa | 8–9 kPa | 8–11 kPa | ≥18 kPa |
| Hepatitis C | 2–7 kPa | 8–9 kPa | 9–14 kPa | ≥14 kPa |
| HIV/HCV Co-infection | 2–7 kPa | 7–11 kPa | 11–14 kPa | ≥14 kPa |
| Cholestatic Disease | 2–7 kPa | 7–9 kPa | 9–17 kPa | ≥17 kPa |
| NAFLD | 2–7 kPa | 7.5–10 kPa | 10–14 kPa | ≥14 kPa |
| Alcohol-Related Disease | 2–7 kPa | 7–11 kPa | 11–19 kPa | ≥19 kPa |
What Each Fibrosis Stage Means
- F0–F1 (2–7 kPa): No or minimal scarring. The liver is largely healthy. Focus on lifestyle management and regular monitoring.
- F2 (moderate kPa range): Moderate scarring. Treatment for the underlying cause (e.g., antiviral therapy for Hepatitis) should begin or be optimised.
- F3 (elevated kPa): Significant bridging fibrosis. Aggressive treatment and closer monitoring are necessary.
- F4 (highest kPa range): Cirrhosis. The liver structure is severely damaged. Risk of liver failure and liver cancer is substantially elevated. Specialist care is essential.
Fibroscan vs. Liver Biopsy: A Direct Comparison
Fibroscan (Transient Elastography)
- Completely non-invasive
- Painless — feels like gentle tapping
- Takes ~15 minutes
- No anaesthesia or sedation required
- No recovery time needed
- Measures both fibrosis AND liver fat (CAP)
- Repeatable for monitoring progress
- Lower cost than biopsy
- No risk of bleeding or infection
Liver Biopsy
- Invasive — requires needle insertion
- Painful; sedation or anaesthesia needed
- Procedure + recovery takes hours
- Risk of bleeding (1 in 1,000) and infection
- Samples only a tiny fraction of liver tissue
- More expensive
- Hospitalisation sometimes required
- Cannot be repeated frequently
Clinical guidelines from leading hepatology bodies now recommend Fibroscan as the preferred first-line test for assessing liver fibrosis in most patients with chronic liver disease. Biopsy is reserved for cases where the Fibroscan result is inconclusive or when additional histological information is needed.
Who Should Get a Fibroscan?
Your doctor may recommend a Fibroscan if you have or are at risk of any of the following conditions:
- Known or suspected Non-Alcoholic Fatty Liver Disease (NAFLD) or NASH
- Chronic Hepatitis B or C infection
- Long-term heavy alcohol consumption or alcohol-related liver disease
- Type 2 diabetes, obesity, or metabolic syndrome — known risk factors for fatty liver
- Unexplained elevated liver enzymes (ALT, AST) on blood tests
- Existing liver disease — to monitor progression or response to treatment
- Autoimmune hepatitis or primary biliary cholangitis
- Prior to or after liver transplant evaluation
Important: Fibroscan is not recommended during pregnancy, or for patients with an implanted cardiac defibrillator.
Discuss your full medical history with your doctor before the test.
How to Prepare for a Fibroscan
Proper preparation improves the accuracy of results. Follow these guidelines before your appointment:
- Fast for at least 3 hours before the test — avoid solid food and large quantities of fluids. A light drink of water is fine.
- Avoid alcohol for at least 24 hours beforehand, as it causes transient inflammation that temporarily stiffens the liver and inflates readings.
- Wear comfortable, loose clothing that allows easy access to your right ribcage.
- Inform the technician if you are pregnant, have a pacemaker, or have active hepatitis flares.
- No blood tests, sedatives, or injections are needed.
How to Reduce Your Fibroscan Score Over Time
Liver fibrosis is partially reversible when underlying causes are treated and healthy habits are adopted. Improvements typically appear on repeat Fibroscan after 6–12 months of sustained lifestyle changes.
- Stop or strictly limit alcohol consumption — the single most impactful change for alcohol-related liver disease.
- Follow a liver-friendly diet: Reduce refined carbohydrates, trans fats, and ultra-processed foods. Increase vegetables, lean protein, and whole grains.
- Exercise regularly: Even 150 minutes of moderate aerobic exercise per week has been shown to reduce liver fat and stiffness in NAFLD patients.
- Achieve and maintain a healthy weight: A 7–10% reduction in body weight is associated with significant improvement in liver fat and fibrosis scores in overweight patients.
- Control blood sugar and cholesterol: NAFLD is closely linked to insulin resistance; managing metabolic health directly benefits the liver.
- Treat the underlying infection: Antiviral therapy for Hepatitis B or C can dramatically reverse fibrosis, sometimes converting F3–F4 scores back to F1 within years.
Your Health, Our Priority
Our team of dedicated professionals combines medical expertise, advanced technology, and a patient-first approach to ensure you receive the highest quality treatment every time you visit.